BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21572435)

  • 1. COP1 is a tumour suppressor that causes degradation of ETS transcription factors.
    Vitari AC; Leong KG; Newton K; Yee C; O'Rourke K; Liu J; Phu L; Vij R; Ferrando R; Couto SS; Mohan S; Pandita A; Hongo JA; Arnott D; Wertz IE; Gao WQ; French DM; Dixit VM
    Nature; 2011 May; 474(7351):403-6. PubMed ID: 21572435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin ligase COP1 coordinates transcriptional programs that control cell type specification in the developing mouse brain.
    Newton K; Dugger DL; Sengupta-Ghosh A; Ferrando RE; Chu F; Tao J; Lam W; Haller S; Chan S; Sa S; Dunlap D; Eastham-Anderson J; Ngu H; Hung J; French DM; Webster JD; Bolon B; Liu J; Reja R; Kummerfeld S; Chen YJ; Modrusan Z; Lewcock JW; Dixit VM
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11244-11249. PubMed ID: 30322923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis.
    Lunardi A; Varmeh S; Chen M; Taulli R; Guarnerio J; Ala U; Seitzer N; Ishikawa T; Carver BS; Hobbs RM; Quarantotti V; Ng C; Berger AH; Nardella C; Poliseno L; Montironi R; Castillo-Martin M; Cordon-Cardo C; Signoretti S; Pandolfi PP
    Cancer Discov; 2015 May; 5(5):550-63. PubMed ID: 25653093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Cell Insulin Secretion Requires the Ubiquitin Ligase COP1.
    Suriben R; Kaihara KA; Paolino M; Reichelt M; Kummerfeld SK; Modrusan Z; Dugger DL; Newton K; Sagolla M; Webster JD; Liu J; Hebrok M; Dixit VM
    Cell; 2015 Dec; 163(6):1457-67. PubMed ID: 26627735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer.
    Barros-Silva JD; Paulo P; Bakken AC; Cerveira N; Løvf M; Henrique R; Jerónimo C; Lothe RA; Skotheim RI; Teixeira MR
    Neoplasia; 2013 Jul; 15(7):720-6. PubMed ID: 23814484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer.
    Oh S; Shin S; Lightfoot SA; Janknecht R
    Cancer Res; 2013 Aug; 73(16):5110-9. PubMed ID: 23774214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E3 ubiquitin ligase RFWD2 controls lung branching through protein-level regulation of ETV transcription factors.
    Zhang Y; Yokoyama S; Herriges JC; Zhang Z; Young RE; Verheyden JM; Sun X
    Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7557-62. PubMed ID: 27335464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
    Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
    Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors.
    Xie Y; Cao Z; Wong EW; Guan Y; Ma W; Zhang JQ; Walczak EG; Murphy D; Ran L; Sirota I; Wang S; Shukla S; Gao D; Knott SR; Chang K; Leu J; Wongvipat J; Antonescu CR; Hannon G; Chi P; Chen Y
    J Clin Invest; 2018 Apr; 128(4):1442-1457. PubMed ID: 29360641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss.
    Chen Y; Chi P; Rockowitz S; Iaquinta PJ; Shamu T; Shukla S; Gao D; Sirota I; Carver BS; Wongvipat J; Scher HI; Zheng D; Sawyers CL
    Nat Med; 2013 Aug; 19(8):1023-9. PubMed ID: 23817021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression.
    Higgins J; Brogley M; Palanisamy N; Mehra R; Ittmann MM; Li JZ; Tomlins SA; Robins DM
    Horm Cancer; 2015 Jun; 6(2-3):67-86. PubMed ID: 25631336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer.
    Han B; Mehra R; Dhanasekaran SM; Yu J; Menon A; Lonigro RJ; Wang X; Gong Y; Wang L; Shankar S; Laxman B; Shah RB; Varambally S; Palanisamy N; Tomlins SA; Kumar-Sinha C; Chinnaiyan AM
    Cancer Res; 2008 Sep; 68(18):7629-37. PubMed ID: 18794152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.
    Oh S; Shin S; Janknecht R
    Biochim Biophys Acta; 2012 Aug; 1826(1):1-12. PubMed ID: 22425584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.
    Liu CY; Yu T; Huang Y; Cui L; Hong W
    J Biol Chem; 2017 Jun; 292(22):9420-9430. PubMed ID: 28408625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.
    Mesquita D; Barros-Silva JD; Santos J; Skotheim RI; Lothe RA; Paulo P; Teixeira MR
    Oncotarget; 2015 Mar; 6(7):5217-36. PubMed ID: 25595908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells.
    Zong Y; Xin L; Goldstein AS; Lawson DA; Teitell MA; Witte ON
    Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12465-70. PubMed ID: 19592505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice.
    Migliorini D; Bogaerts S; Defever D; Vyas R; Denecker G; Radaelli E; Zwolinska A; Depaepe V; Hochepied T; Skarnes WC; Marine JC
    J Clin Invest; 2011 Apr; 121(4):1329-43. PubMed ID: 21403399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COP1 is downregulated in renal cell carcinoma (RCC) and inhibits the migration of RCC ACHN cells in vitro.
    Ta L; Xuan C; Xing N; Zhu X
    Mol Med Rep; 2016 Aug; 14(2):1371-8. PubMed ID: 27278120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.
    Shin S; Kim TD; Jin F; van Deursen JM; Dehm SM; Tindall DJ; Grande JP; Munz JM; Vasmatzis G; Janknecht R
    Cancer Res; 2009 Oct; 69(20):8102-10. PubMed ID: 19789348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.
    Shin S; Oh S; An S; Janknecht R
    Oncol Rep; 2013 Jan; 29(1):306-14. PubMed ID: 23076342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.